Marker Therapeutics, Inc. Announces Closing of Public Offering of Common Stock Mar 16, 2021 04:57PM
Marker Therapeutics (MRKR) Prices 28.572M Share Common Offering at $1.75/Sh Mar 12, 2021 08:02AM
Marker Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock Mar 12, 2021 08:00AM
Marker Therapeutics (MRKR) AML Trial Expected to Begin in 2021 - Roth Capital Jan 6, 2021 06:07AM
Marker Therapeutics (MRKR) PT Lowered to $8 at Roth Capital After Investment Conference Presentation Dec 4, 2019 06:35AM


May 30, 2019 02:45AM Roth Capital Starts Marker Therapeutics (MRKR) at Buy